{"version":"1.0","provider_name":"BioVariance - data-driven diagnostics","provider_url":"https:\/\/biovariance.com\/de\/","author_name":"Marco Vollath","author_url":"https:\/\/biovariance.com\/de\/author\/advancemedia\/","title":"HORIZON 2020 - REVERT - BioVariance - data-driven diagnostics","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rBe0yXZYrQ\"><a href=\"https:\/\/biovariance.com\/de\/pressemitteilungen\/horizon-2020-revert\/\">HORIZON 2020 &#8211; REVERT<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/biovariance.com\/de\/pressemitteilungen\/horizon-2020-revert\/embed\/#?secret=rBe0yXZYrQ\" width=\"600\" height=\"338\" title=\"&#8222;HORIZON 2020 &#8211; REVERT&#8220; &#8211; BioVariance - data-driven diagnostics\" data-secret=\"rBe0yXZYrQ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Waldsassen \u2013 BioVariance hat im Rahmen von HORIZON 2020, einem Rahmenprogramm der EU f\u00fcr Forschung und Innovation, eine Zusage von der Europ\u00e4ischen Kommission f\u00fcr das innovative Projekt REVERT erhalten. Das Ziel von REVERT ist die Identifikation der effektivsten und kosteneffizientesten Therapie f\u00fcr Patienten mit inoperablem und metastasierendem Darmkrebs. An dem Kooperationsprojekt sind 14 multidisziplin\u00e4re Partner [&hellip;]","thumbnail_url":"https:\/\/panzerneumann.de\/biovariance-old\/wp-content\/uploads\/2020\/08\/revert_horizo2020_gruppenfoto_zuschnitt2-300x167.jpg"}